In Q4 of fiscal 2023, the quarter ended Dec 31, 2023, Safeguard Scientifics Inc used $818,000 of cash from operations, down 36.8% from the same quarter a year earlier.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.
| Line |
Q4 FY2023
Dec 31, 2023
|
Q3 FY2023
Sep 30, 2023
|
Q2 FY2023
Jun 30, 2023
|
Q1 FY2023
Mar 31, 2023
|
Q4 FY2022
Dec 31, 2022
|
Q3 FY2022
Sep 30, 2022
|
Q2 FY2022
Jun 30, 2022
|
Q1 FY2022
Mar 31, 2022
|
|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||
| Operating cash flow |
-1
-36.8%
|
-0
+23.5%
|
-1
-3.2%
|
-1
+7.3%
|
-1
+77.9%
|
-1
+21.0%
|
-1
+57.4%
|
-1
+53.6%
|
| Investing | ||||||||
| Investing cash flow |
1
+376.9%
|
2
+220.3%
|
4
+2251.3%
|
-1
+64.9%
|
-0
-108.8%
|
-2
-103.5%
|
0
-95.0%
|
-3
-136.8%
|
| Financing | ||||||||
| Stock buybacks |
0
-100.0%
|
0
-100.0%
|
0
-100.0%
|
0
-90.4%
|
1
-97.7%
|
0
+560.8%
|
1
-40.6%
|
1
|
| Financing cash flow |
-6
-552.0%
|
-0
+94.6%
|
-0
+97.4%
|
-0
+75.2%
|
-1
+97.7%
|
-0
-397.3%
|
-1
+38.4%
|
-1
-1296.6%
|
| Shareholder returns | ||||||||
| Returned to shareholders |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
| Ratios | ||||||||
| Cash conversion |
—
|
-0.46x
|
—
|
—
|
—
|
—
|
-2.27x
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Investors, NEC (SIC 6799)
- Listed as
- SFES (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- PA
- Headquarters
- Radnor, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 86115
- Former names
- SAFEGUARD SCIENTIFICS INC ET AL (until Jun 5, 2003)
Other Investors, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.